Anne Sissel is managing director at Baxter Ventures, the venture capital arm of Baxter International. The team looks to make investments in companies working to improve patient care around the world.
On a panel at health-tech incubator Matter in February 2015, Sissel discussed what kind of investments she’d be looking to make: “We’re all talking about this move from fee-for-volume to fee-for-value. How do you measure that? How do you predict that? How do you ensure your patients are getting the best care?” she said. “We see technology as the best way to be able to do that.”
Sissel was previously on the founding and executive teams of Veracyte, a life sciences company working to improve patient outcomes, and also worked in the investment banking division of Goldman Sachs.
Sissel holds an MBA from the Wharton School of the University of Pennsylvania and a bachelor’s degree in finance from Indiana University. She also is a Chartered Financial Analyst charterholder. She lives in Chicago.